Clinical trial
Study on the Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases Subject to Chronic Transfusion Support.
NCT04526405 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases Subject to Chronic Transfusion Support.
- Lead sponsor
- University of Milano Bicocca
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 14, 2020
- Completion date
- November 3, 2020
- Enrollment
- 63 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, thalassemia major